MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

Armed with positive results in two phase 3 trials, MSD is poised to be the first drugmaker to file for approval of an oral PCSK9 inhibitor for lowering cholesterol. Top-line results from the CORALreef ...

Noblis MSD, a Noblis subsidiary and leading provider of science, technology and engineering services to the U.S. military, today announced that it has been awarded a $45 million contract to provide ...

Max Verstappen snatched a crucial pole position for the title-deciding Abu Dhabi Grand Prix. See the full starting grid for ...

The majority of Mississippi grant approvals will fund projects through site development, infrastructure improvements and ...

Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.